GSK Investigator-sponsored studies programme





Title:

Belimumab ISS proposals

Summary:

Currently accepting belimumab ISS proposals, with next review committee in February 2018

Details:

Details:
Belimumab ISS Proposals can be submitted any time during the year, however GSK belimumab ISS committee will review them once a year (not applicable for other GSK ISS). In order to have your proposal reviewed by the next belimumab ISS committee (to be held in February 2018), please make sure to submit your proposal by 15th Jan, 2018. GSK belimumab ISS committee will communicate to investigators proposals that fall within current areas of interest and will be provisionally approved by March 2018. The investigators will then be requested to submit full protocol and ICF in English by April 2018. GSK will review these documents and come back to you with a final decision as soon as possible.

Summary of key dates:
-Submission of Proposal by Investigator: January 15, 2018
-Committee Review / Selection by GSK: February 2018
-Communication to Investigators by GSK: March 2018
-Submission of full Protocol and ICF by investigators: April 2018

GSK belimumab ISS committee is committed to the above review timelines, however, the review process might take longer for certain proposals.

The following areas are of interest to the Belimumab ISS Committee:
- Use of belimumab in SLE in clinical practice
- Association of biomarkers with clinical outcomes in SLE
- Contribution to scientific knowledge of SLE disease state
- BLyS inhibition with focus on other systemic and non-systemic autoimmune diseases and consistent with the belimumab mechanism of action (MOA)
- Contribution to scientific knowledge of belimumab
- Critical unmet medical needs based on belimumab MOADetails and timelines described above are not applicable and cannot be used as reference for other GSK ISS areas of interest.

Details and timelines described above are not applicable and cannot be used as reference for other GSK ISS areas of interest.

If you have any questions, please contact your local GSK Medical contact (e.g. MSL, others)

Click on "Submit Application" below to begin the process.

Powered by ideaPoint, Inc.

Posted: 08-24-2017
Created: 08-22-2017
Modified: 11-16-2017
 




Terms of use Accessibility Cookie policy Privacy
© 2001-2017 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.